EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS Asset Resilience Ratio
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS asset resilience ratio. EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (ECILC) has an Asset Resilience Ratio of 0.46% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ECILC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (2000–2024)
Asset resilience ratio of EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS from 2000 to 2024. This chart shows how EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's Asset Resilience Ratio has changed over time. Read debt load of EIS Eczacibasi Ilac Sinai ve Finansal Ya for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EIS Eczacibasi Ilac Sinai ve Finansal Ya asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 0% |
| Short-term Investments | TL322.48 Million | 0.46% |
| Total Liquid Assets | TL322.48 Million | 0.46% |
Asset Resilience Insights
- Limited Liquidity: EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS Industry Peers by Asset Resilience Ratio
Compare EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS Asset Resilience Ratio by Year (2000–2024)
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS asset resilience ratio by year from 2000 to 2024. The table below shows the annual Asset Resilience Ratio data for EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.53% | TL298.71 Million ≈ $6.69 Million |
TL56.20 Billion ≈ $1.26 Billion |
+0.05pp |
| 2023-12-31 | 0.48% | TL303.65 Million ≈ $6.80 Million |
TL62.80 Billion ≈ $1.41 Billion |
-1.19pp |
| 2022-12-31 | 1.67% | TL388.04 Million ≈ $8.69 Million |
TL23.23 Billion ≈ $520.33 Million |
-0.35pp |
| 2021-12-31 | 2.02% | TL166.59 Million ≈ $3.73 Million |
TL8.26 Billion ≈ $185.11 Million |
+1.60pp |
| 2020-12-31 | 0.42% | TL25.07 Million ≈ $561.59K |
TL5.97 Billion ≈ $133.72 Million |
+0.39pp |
| 2019-12-31 | 0.03% | TL1.25 Million ≈ $28.09K |
TL4.84 Billion ≈ $108.37 Million |
+0.00pp |
| 2018-12-31 | 0.03% | TL1.15 Million ≈ $25.67K |
TL4.46 Billion ≈ $99.81 Million |
+0.02pp |
| 2017-12-31 | 0.01% | TL354.00K ≈ $7.93K |
TL3.83 Billion ≈ $85.81 Million |
-0.02pp |
| 2016-12-31 | 0.03% | TL1.08 Million ≈ $24.23K |
TL3.99 Billion ≈ $89.43 Million |
-0.03pp |
| 2015-12-31 | 0.06% | TL2.06 Million ≈ $46.25K |
TL3.37 Billion ≈ $75.48 Million |
+0.04pp |
| 2014-12-31 | 0.02% | TL763.00K ≈ $17.09K |
TL3.26 Billion ≈ $73.09 Million |
+0.01pp |
| 2013-12-31 | 0.01% | TL308.00K ≈ $6.90K |
TL3.44 Billion ≈ $76.98 Million |
0.00pp |
| 2012-12-31 | 0.01% | TL372.00K ≈ $8.33K |
TL3.48 Billion ≈ $77.94 Million |
-0.04pp |
| 2011-12-31 | 0.05% | TL1.40 Million ≈ $31.45K |
TL3.03 Billion ≈ $67.90 Million |
-0.08pp |
| 2010-12-31 | 0.13% | TL3.42 Million ≈ $76.58K |
TL2.66 Billion ≈ $59.63 Million |
-0.20pp |
| 2009-12-31 | 0.33% | TL8.17 Million ≈ $182.99K |
TL2.49 Billion ≈ $55.75 Million |
-0.40pp |
| 2008-12-31 | 0.73% | TL14.82 Million ≈ $332.04K |
TL2.02 Billion ≈ $45.33 Million |
-0.71pp |
| 2005-12-31 | 1.44% | TL18.77 Million ≈ $420.31K |
TL1.30 Billion ≈ $29.14 Million |
-2.00pp |
| 2004-12-31 | 3.44% | TL29.52 Million ≈ $661.13K |
TL858.48 Million ≈ $19.23 Million |
+3.44pp |
| 2003-12-31 | 0.00% | TL7.99 Billion ≈ $178.96 Million |
TL739.70 Trillion ≈ $16.57 Trillion |
-4.26pp |
| 2002-12-31 | 4.26% | TL11.19 Trillion ≈ $250.52 Billion |
TL262.36 Trillion ≈ $5.88 Trillion |
-0.48pp |
| 2001-12-31 | 4.74% | TL8.29 Trillion ≈ $185.77 Billion |
TL174.96 Trillion ≈ $3.92 Trillion |
-3.61pp |
| 2000-12-31 | 8.35% | TL10.58 Trillion ≈ $236.87 Billion |
TL126.63 Trillion ≈ $2.84 Trillion |
-- |
About EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment develops real estate properties; engages… Read more